Meeting
2023 ASCO Genitourinary Cancers Symposium
Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.
Authors
Regina Girones
Medical Oncology Service. Hospital Universitario y Politecnico La Fe, Valencia, Spain
Regina Girones , Maria Arnal , Silvia Forcano Sr.
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 90)
DOI
10.1200/JCO.2023.41.6_suppl.90
Abstract #
90
Poster Bd #
D10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The impact of CARE Frailty Index on overall survival in older adults with hepatocellular carcinoma.
First Author: Ahmet Anil Ozluk
Poster
2023 ASCO Annual Meeting
Understanding treatment toxicity patterns through remote symptom monitoring and examining the effect of frailty in older men with metastatic prostate cancer.
First Author: Milothy Parthipan
Poster
2023 ASCO Annual Meeting
Frailty IO: Frailty parameters and incidence of immune related adverse events in older patients treated with immune checkpoint blockers (ICB).
First Author: Capucine Baldini
Poster
2023 ASCO Annual Meeting
Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.
First Author: Howard Jinsoo Lee Jr.